Diadema Partners LP
All holdings · as of Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Edgewise Therapeutics, Inc. | $744.5K | 0.4% |
| Viridian Therapeutics, Inc. | $657.1K | 0.4% |
| INDIVIOR PLC | $621.4K | 0.4% |
| Vir Biotechnology, Inc. | $603.0K | 0.4% |
| LIGAND PHARMACEUTICALS INC | $564.8K | 0.3% |
| Upstream Bio, Inc.UPB | $556.6K | 0.3% |
| Stoke Therapeutics, Inc. | $545.3K | 0.3% |
| Equillium, Inc. | $538.5K | 0.3% |
| UROGEN PHARMA LTD | $510.8K | 0.3% |
| Immunome Inc. | $483.3K | 0.3% |
| PALISADE BIO, INC. | $390.2K | 0.2% |
| PROQR THRAPEUTICS N V | $338.4K | 0.2% |
| HARMONY BIOSCIENCES HOLDINGS INC | $280.6K | 0.2% |
| Aardvark Therapeutics, Inc.AARD | $208.5K | 0.1% |
| Neuphoria Therapeutics Inc.NEUP | $194.0K | 0.1% |
| PLIANT THERAPEUTICS, INC.PLRX | $176.8K | 0.1% |
| BeOne Medicines Ltd.ONC | $172.8K | 0.1% |
| Foghorn Therapeutics Inc. | $165.4K | 0.1% |
| TALPHERA, INC. | $156.1K | 0.1% |
| PURETECH HEALTH PLC | $123.8K | 0.1% |
| Inhibrx Biosciences, Inc. | $102.6K | 0.1% |
| Edesa Biotech, Inc. | $76.7K | 0.0% |
| Vistagen Therapeutics, Inc.VTGN | $66.2K | 0.0% |